Breast Cancer Awareness Month: My Story, and What I Want You to Know

Breast Cancer Awareness Month: My Story, and What I Want You to Know
10/22/2026

Breast Cancer Awareness Month: My Story, and What I Want You to Know

By Diane Lietz, MSN, APRN, FNP-C | VGM Health | 8 min read

Every October, we see pink ribbons everywhere. This year, I want to go a little deeper, because breast health is personal for me.

My own story

Breast cancer runs in my family. My mom and my paternal grandmother were both breast cancer survivors. (They later passed away from other health conditions, not cancer.) So when my own mammogram came back abnormal in the summer of 2024, I knew exactly what that could mean.

The timing felt unreal. I was in the middle of stepping back from family practice, and for the first time in a long time, I was planning to take some time just for me: to focus on VGM Health, my family, and myself. Then my mammogram showed a large area of calcifications in one breast, with a suspicious spot inside it. My first thought was, "No way. This can't be happening to me. Not now."

That first result was only the beginning. Next came additional imaging, and then several biopsies. The biopsies themselves weren't that painful, but every step was nerve-wracking. Each time, the same question ran through my head: "What are they going to find?" I prayed for patience, and for peace with whatever the answer turned out to be.

Those weeks of waiting changed the way I see my own work. As a provider, I've been the one making that phone call: "Something looks abnormal, and we need to take a closer look." Giving those results is hard, because I know that the moment a patient hears those words, cancer is the first thing on their mind. This time, I was the one waiting for the phone to ring. Going through it myself has given me a much deeper empathy for my patients and for what it's like to move through the healthcare system: the waiting, the not knowing, and the anticipation of that call with results.

When my results finally came, they brought relief, with a catch. Thankfully, mine wasn't cancer... yet. The biopsies showed atypical ductal hyperplasia (ADH). ADH isn't cancer, but it's a change in the breast cells that raises the risk of developing cancer later. That left me with a choice: watch and wait, or remove it. Because the area of calcifications was so large, removing it meant a mastectomy, not a lumpectomy.

With my family history, I didn't want to sit and wait to see whether ADH would turn into cancer. For me, a mastectomy was the right decision, and I had surgery in the fall of 2024. Thankfully, the pathology from my mastectomy showed no additional ADH and no cancer. Genetic testing didn't find a mutation, and today I have regular breast MRIs along with my mammograms.

Recovery didn't end with that first surgery. I've had some reconstruction surgeries since then, and it's been a process, but I'm still grateful I acted when I did.

It wasn't an easy road, and I'm grateful for the family and friends who supported me through every step. That experience is a big part of why I talk about screening the way I do. But breast health mattered to me long before my own scare. Over the years, I've given community talks on breast cancer and taught high school students about cancer risk, because knowing your risk early really can change the outcome.

Every woman's situation is different. A mastectomy was the right choice for me, given my history. It isn't the right choice for everyone with ADH, and that's a decision to make with your own care team.

I'm sharing my story because I want you to hear this from someone who has been on both sides of that phone call: don't put off your mammogram. Mine found something early, while I still had choices. Below, I've pulled together what I want everyone to know: what ADH really means, what the screening guidelines say, and why this matters for younger women and for men.

What is ADH, and how often does it lead to cancer?

Atypical ductal hyperplasia (ADH) means some cells lining the milk ducts are growing in an abnormal pattern. It isn't cancer, but it's considered a "high-risk" finding. Here's what the research shows:

  • It's not rare. Atypical hyperplasia (ADH or its close cousin, atypical lobular hyperplasia) shows up in about 1 in 10 breast biopsies that come back benign (Hartmann et al., 2015).
  • It raises future risk about 4 times. In a large Mayo Clinic study, about 30% of women with atypical hyperplasia developed breast cancer within 25 years, roughly 1% per year. That also means most women with ADH (about 70%) did not develop breast cancer in that time.
  • Sometimes cancer is already hiding nearby. A needle biopsy only samples a small piece. When the area around ADH is surgically removed, cancer is found in it in about 15–30% of cases. A review of more than 6,400 ADH lesions found cancer in 29% of those removed with surgery (Schiaffino et al., 2019). That's why removing the area is the usual next step.
  • There are options after ADH. These can include closer screening (sometimes adding breast MRI), medications that lower breast cancer risk, and regular follow-up with your care team.

In my case, removing the area was the recommended step, and because it was so large, that meant a mastectomy rather than a lumpectomy.

What the screening guidelines say (and why they don't all agree)

If you've heard different advice about mammograms, you're not imagining it. Major medical organizations recommend slightly different schedules for women at average risk:

  • U.S. Preventive Services Task Force (2024): a mammogram every 2 years, ages 40 to 74.
  • American College of Obstetricians and Gynecologists: every 1 to 2 years, starting at 40.
  • American College of Radiology: every year, starting at 40, plus a breast cancer risk assessment by age 25 for all women.
  • American Cancer Society: every year from 45 to 54 (with the option to start at 40), then every 2 years from 55 (with the option to continue yearly).

My recommendation: As a nurse practitioner, and as someone whose mammogram changed her life, I encourage women to get a mammogram every year starting at 40, unless their provider recommends a different plan based on their personal risk. Talk with your primary care provider or OB-GYN about the screening schedule that's right for you.

Why this matters even if you're under 40

The American Cancer Society's 2026 report notes that breast cancer rates continue to rise, especially among women younger than 50.

That's why the American College of Radiology recommends that every woman have a breast cancer risk assessment by age 25. Some women are at higher-than-average risk and may need to start screening earlier, or add breast MRI. Higher risk can include:

  • A strong family history of breast or ovarian cancer (on either side of the family)
  • A known genetic mutation, such as BRCA1 or BRCA2
  • Radiation to the chest at a young age
  • A personal history of high-risk breast changes (like ADH)
  • Being of Black or Ashkenazi Jewish descent

If you don't know your family history, now is a great time to ask.

Men get breast cancer too

Breast cancer in men is rare, but it's real. I've personally cared for a man who went through it.

The American Cancer Society estimates that in 2026, about 2,670 men in the U.S. will be diagnosed with invasive breast cancer, and about 530 will die from it. A man's average lifetime risk is about 1 in 755. Men who carry a BRCA1 or BRCA2 mutation have a higher risk, and about 1 in 5 men with breast cancer has a family history of the disease.

Because men aren't routinely screened, the best tool is awareness. Men should get checked if they notice:

  • A lump or swelling in the chest
  • Nipple changes (turning inward, discharge, redness, or scaling)
  • Skin changes such as dimpling or puckering

And if breast cancer runs in your family, make sure your provider knows, whether you're a man or a woman.

The bottom line

  • Schedule your mammogram. If you're 40 or older and it's been more than a year, this is your sign.
  • Know your risk, especially your family history, on both sides.
  • If a biopsy shows ADH, ask about your options: removal, closer screening, and risk-lowering medications.
  • Men: don't ignore changes in your chest.

If my story does one thing, I hope it gets you to pick up the phone and schedule your mammogram.

Read next: the question I hear most often from women is, "Will hormone therapy raise my breast cancer risk?" Here's what the research really shows, and what's changed →

For mammograms, screening, and any breast health concerns, please see your primary care provider or OB-GYN. And if you're navigating perimenopause or menopause and have questions about hormone therapy, I'm always glad to talk them through, one on one.

Questions about perimenopause, menopause, or hormone therapy? Start Your Free Quick Consult →

Diane Lietz, MSN, APRN, FNP-C
VGM Health

This article is for educational purposes only and isn't a substitute for personalized medical advice. Please talk with your own healthcare provider about your screening schedule and treatment options.


References

  1. Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical hyperplasia of the breast: risk assessment and management options. N Engl J Med. 2015;372(1):78–89. https://doi.org/10.1056/NEJMsr1407164
  2. Schiaffino S, et al. Upgrade rate of percutaneously diagnosed pure atypical ductal hyperplasia: systematic review and meta-analysis of 6458 lesions. Radiology. 2019;294(1):76–86. https://doi.org/10.1148/radiol.2019190748
  3. US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930. https://doi.org/10.1001/jama.2024.5534
  4. Monticciolo DL, et al. Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR. J Am Coll Radiol. 2023;20(9):902–914. https://doi.org/10.1016/j.jacr.2023.04.002
  5. American Cancer Society. Key Statistics for Breast Cancer in Men (2026). https://www.cancer.org/cancer/types/breast-cancer-in-men/about/key-statistics.html
  6. Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A. Cancer statistics, 2026. CA Cancer J Clin. 2026;76(1):e70043. https://doi.org/10.3322/caac.70043

Diane Lietz, MSN, APRN, FNP-C is the founder and sole clinician at VGM Health in Springfield, IL. She offers in-person and telehealth care throughout Illinois.